| |
|
|
Il Sung Pharmaceutical (003120) |
|
|
STOCK |
|
|
| Address |
44-7,WONHYORO 1-GA, YONGSAN-GU,SEOUL |
| Home Page |
www.ilsung-ph.co.kr
|
| Established |
1961. 2.15 |
Tel |
02-3271-8800 |
| Listed |
1985. 1.14 |
IR |
02-3271-8734 |
| Common shares O/S |
2,660,000 |
President |
Yun,Seok Geun |
| Preferred shares O/S |
|
No.of Employees |
293(2008. 9) |
| Sales remained well although sales of its key antibiotic medicine remained sluggish. Its profit margin increased sharply on increased gains from sales of marketable securities. Its financial status is stable on ample liquidity, low debts and good cash flows. |
| Sales are expected to increase on a variety of production lines such as antibiotic medicines. Its profitability is expected to fall on increased costs of imported raw materials, and reduced gains from financial investment. The company is to unveil a set of new drugs including pain reliever and contrast medium licensed by Bracco of Italy. |
|
  |
(date: 2008.06, unit : %) |
| Name |
CISCO |
Yoon Hyeongjin |
Yoon Seokgeun |
| Portion |
18.9 |
9.2 |
6.1 |
|
 |
(unit : %) |
| Sales |
Augmentin |
27.4 |
Cost |
Raw Materials |
|
| Ilsungiofamiro(300/100ml) |
26.1 |
Labors |
|
| Others |
31.4 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
85. 1 |
85.10 |
86.10 |
87. 6 |
98. 7 |
| Type |
LI |
RI |
RI |
RI |
RI |
| Amount |
43.00 |
20.00 |
20.00 |
20.00 |
30.00 |
|
|
|
|
